ISSN 2063-5346
For urgent queries please contact : +918130348310

The Future Drug Development by Big Pharma and Its Contenders

Main Article Content

Dr. Sushil Dohare
» doi: 10.31838/ecb/2023.12.si6.237


There are a number of quirks in the pharmaceutical industry's structure and operations that set it apart from other business sectors. While the general public may not be aware of these quirks, they have a major bearing on the time and effort required to bring new pharmaceuticals to market. Developing a new treatment is a long and costly process that comes with a lot of uncertainty about whether or not it will be effective. This article analyses the difficulties of doing research and development, particularly those posed by the natural world. Future commercial and technological advances in the area, such as the creation of a greener pharmacy, will be studied once the economic realities and restrictions of the company and its current issues have been reviewed.

Article Details